| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Zinc isotope |
Is a |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc measurement, urine |
Has measured component (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Spelters' fever |
Causative agent (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc poisoning |
Causative agent (attribute) |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc measurement |
Has measured component (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Blood zinc measurement |
Has measured component (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Serum zinc measurement |
Has measured component (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Plasma zinc measurement |
Has measured component (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc adverse reaction |
Causative agent (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc measurement, urine |
Component |
False |
Zinc |
Inferred relationship |
Some |
2 |
| Zinc measurement |
Component |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Blood zinc measurement |
Component |
False |
Zinc |
Inferred relationship |
Some |
2 |
| Serum zinc measurement |
Component |
False |
Zinc |
Inferred relationship |
Some |
2 |
| Plasma zinc measurement |
Component |
False |
Zinc |
Inferred relationship |
Some |
2 |
| Zinc gluconate |
Is a |
False |
Zinc |
Inferred relationship |
Some |
|
| Topical zinc adverse reaction |
Causative agent (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Topical zinc allergy |
Causative agent (attribute) |
False |
Zinc |
Inferred relationship |
Some |
|
| Minerals - zinc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc salts |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc sulfate monohydrate 125 milligram/1 each conventional release effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc sulfate 220 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate 2.5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate+epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc compound paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc 32% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc 15% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc+castor oil ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate 1% lotion BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing zinc AND/OR zinc compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing zinc in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing zinc in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc sulfate 220 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate 25mg/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc (as zinc acetate) 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Naphazoline hydrochloride + polyvinyl alcohol + zinc sulfate 0.02%wv/0.25%wv/0.25%wv drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc Sulfate 500micromol/10mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing zinc in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc stearate |
Is a |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing zinc sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc compound |
Is a |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc supplement |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc adverse reaction |
Causative agent (attribute) |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc+starch+talc dusting powder BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc+coal tar paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc+ichthammol cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc+salicylic acid paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc+salicylic acid paste half strength |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Erythromycin 40 mg/mL and zinc acetate 12 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing erythromycin and zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing ichthammol and zinc (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
2 |
| Product containing zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing diphenhydramine and zinc acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| agent topique au zinc |
Is a |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing ichthammol and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc (as zinc acetate) 50 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc (as zinc acetate) 25 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc 50 mg oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing zinc in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Zinc |
Inferred relationship |
Some |
|
| Increase or decrease in zinc content of the diet. |
Direct substance |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Increase in zinc content of the diet compared to the assessed baseline intake of zinc for the individual. |
Direct substance |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Decrease in zinc content of the diet compared to the assessed baseline intake of zinc for the individual. |
Direct substance |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Providing zinc for suboptimal food or fluid intake, iatrogenic deficiency or medical diagnosis. |
Direct substance |
False |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing zinc (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc citrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc cyanide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc undecylenate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc sulfate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc glycinate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc oxide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc phosphide |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc caprylate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc arsenite |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc stearate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc chloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc salt |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc acetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc phenolsulfonate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc arsenate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc diethyldithiocarbamate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc pidolate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc gluconate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc pyrithione |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc propionate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc amino acid chelate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Zinc chloride fumes |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Zinc |
Inferred relationship |
Some |
|
| Product containing precisely zinc 25 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc 50 mg oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Zinc-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Product containing zinc in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
1 |
| Calamine- and dimeticone- and zinc-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
3 |
| Product containing cod liver oil and zinc in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Zinc |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]